Clinical Trial: Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Neovascular Age-related Macular Degeneration
Study Type: INTERVENTIONAL
Official Title: Phase 1/2a Study of the Safety and Bioactivity of AXT107 Injected Suprachoroidally in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)
Brief Summary:
The goal of this clinical trial is to understand the safety of AXT107 injected suprachoroidally in participants with nAMD.The main question[s] it aims to answer are:Safety of the maximum tolerable dose of AXT107Bioactivity and duration of action of AXT107 injected suprachoroidally Participants will be injected with AXT107 and will be followed on a regular monitoring visits through 9 months post single injection.
Read more